Oncology treatment of prostate cancer
Prostate cancer is the second most common cancer in men worldwide. More than 1.4 million cases are recorded each year and therefore our main goal is to provide patients who have already been diagnosed with this disease or are likely to develop it with early and high-quality radiotherapy treatment in one of the most modern medical facilities dedicated to the treatment of cancer patients.
General radiotherapy is provided in one of the hospitals of oncological centres network in the Czech Republic. Besides that, the Oncology Center in Pardubice belongs with its specialization in the prostate to the best oncological centres in Central Europe.
Most effective way of medical treatment which does not require so much parallel care and brings the most relevant results is to focus on two groups of patients. The patients with low-risk and middle-risk diseases of the prostate.
Contact us
Prospective patients who wish to undergo treatment at our cancer centre must meet the parameters listed below or they will not be eligible for treatment.
Parameters which have to be met
- PSA (prostate-specific-antigen) lower than 10
- GS (Gleason score) 6(3+3), Grade group 1
- MRI examination excludes lymphadenopathy and extraprostatic
- PSA (prostate-specific-antigen) 10-20
- GS (Gleason score) +(3+3), Grade group 2 (but not GS 7 (4+3) Grade group 3)
- MRI examination excludes lymphadenopathy and extraprostatic
Patient journey
Where is oncology treatment provided?
General radiotherapy is provided in one of the hospitals of oncological centres network in the Czech Republic. The Oncology centre Multiscan belongs with its specialization in the prostate to the best oncological centres in Central Europe.
